Esophagus and stomach movement problems and aspiration risk in children with neurologic impairment
Official title: The Impact of Upper Gastrointestinal Dysmotility on Aspiration-associated Symptoms
Run by Boston Children's Hospital · NCT05455359 · Data updated 2026-11-12
This trial will test prucalopride versus famotidine to see which better reduces coughing, choking, and other aspiration-associated symptoms in tube-fed children ages 5–21 with neurologic impairment.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 5 Years to 21 Years |
| Sex | All |
| Enrollment | 120 (estimated) |
| Sponsor | Boston Children's Hospital Academic / other |
| Locations | 1 site (Boston, Massachusetts) |
| Status | Recruiting |
| Started | February 13, 2025 |
| Main results expected | May 31, 2027 |
| Study ends | May 31, 2027 |
| Registry record updated | August 3, 2026 |
| Trial ID | NCT05455359 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are children and young adults (5–21 years) who are tube-fed for >90% of calories, have static neurologic impairment, documented aspiration on video fluoroscopic swallow study, and chronic respiratory symptoms occurring at least three times per week.
✕Probably not a fit
Patients with progressive neurologic disease, prior intact Nissen fundoplication, current use of antibiotics, or other protocol exclusion criteria would not be eligible and therefore would not benefit from this study's interventions.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a 10-week, randomized crossover Phase 4 trial at Boston Children's Hospital comparing prucalopride (a prokinetic) to famotidine (an acid suppressant) for treating aspiration-associated symptoms. Participants are children and young adults 5–21 years old who receive >90% of calories by enteral tube, have documented aspiration on video fluoroscopic swallow study, static neurologic impairment, and frequent respiratory symptoms. Each participant receives both study medications in sequence with symptom monitoring to compare effects on coughing, choking, need for oral suctioning, and other aspiration-related outcomes. The trial measures short-term symptomatic response rather than long-term disease modification.
Why it matters
Potential benefit: If successful, the trial could identify a medication strategy that reduces coughing, choking, and other aspiration-associated symptoms and potentially lower aspiration-related complications in this high-risk group.
How similar studies have gone: Prior studies of prokinetic or acid-suppressing approaches for aspiration symptoms in children are limited and have shown mixed results, so applying prucalopride versus famotidine in this specific population is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. are 5-21 years of age; 2. receive \>90% of their calories by enteral tube (i.e., patients take no food or drink by mouth); 3. are determined to be at high risk for aspiration pneumonia based on evidence of impaired airway protective mechanisms, documented by aspiration on video fluoroscopic swallow study; 4. have static neurologic impairment, defined as functional and/or intellectual impairment that results from a chronic neurologic or related diagnosis (e.g., cerebral palsy) with no prospect of progression for at least one year; 5. have chronic respiratory symptoms, defined as coughing, choking, or need for oral suctioning a minimum of three times per week during the prior four weeks. \- Exclusion Criteria: 1. have progressive neurologic impairment; 2. have a history of prior intact Nissen fundoplication; 3. are currently taking oral or inhaled antibiotics, including prophylactic antibiotics; 4. are currently taking or have taken in the last four weeks acid suppression (H2 antagonist or PPI); or 5. are fed by gastrojejunostomy rather than by gastrostomy. -
Where it's running
-
Boston Children's Hospital
Boston, Massachusetts, United States Recruiting
Study contacts
- Study coordinator: Rachel Rosen, MD
- Email: rachel.rosen@childrens.harvard.edu
- Phone: 617-355-0897
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
POEM vs Heller myotomy with Dor fundoplication for achalasia
This trial tests POEM against laparoscopic Heller myotomy with Dor fundoplication to see which procedure better helps adults with achalasia.
-
Medical AI fine-tuning platform for major diseases
This study tests a smart AI system that uses hospital data to help diagnose and guide care for patients with chronic gastritis, gastric cancer, reflux, coronary artery disease, or stroke.
-
Impact of Patient Position on EndoFLIP Measurements in Kids and Young Adults
This study tests whether EndoFLIP measurements differ when patients are in the supine versus left-side position during the procedure.
-
Speedboat UltraSlim™ for POEM in adults with achalasia and other esophageal motility disorders.
This registry will see if using the Speedboat UltraSlim™ device for POEM is safe and effective for adults with achalasia or other esophageal motility disorders.
-
How common symptomatic gastroesophageal reflux is in Czech children aged 8–9 and 12–13
This project will see how common symptomatic GERD is in Czech children aged 8–9 and 12–13 by using school questionnaires and follow-up medical testing for kids who report reflux symptoms.
-
Nissen‑Sleeve versus Roux‑en‑Y gastric bypass for reflux in people with severe obesity
This trial tests whether Nissen‑Sleeve gastrectomy or Roux‑en‑Y gastric bypass better controls GERD symptoms in adults who are eligible for bariatric surgery due to severe obesity.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.